AUM Biosciences Plans To Become A Public Company
entrepreneur.com
news
2022-10-20 13:07:00

You're reading Entrepreneur India, an international franchise of Entrepreneur Media.

AUM Biosciences Pte Ltd (AUM), a clinical-stage biotechnology company, has announced that they have entered into a definitive business combination agreement. Upon closing of the transaction, the combined company will operate under a holding entity to be formed as a Cayman Islands exempted company (Holdco) and intends to trade on the Nasdaq stock market under the ticker symbol AUMB. The transaction reflects a pre-money equity value of $400 million for AUM and is expected to close in the first quarter of 2023.
